Photooxidation Responsive Elastin-Like Polypeptide Conjugates for Photodynamic Therapy Application
Author(s) -
Vüsala İbrahimova,
José A. GonzálezDelgado,
Ma Levêque,
Tomás Torres⊗,
Élisabeth Garanger,
Sébastien Lecommandoux
Publication year - 2021
Publication title -
bioconjugate chemistry
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.279
H-Index - 172
eISSN - 1520-4812
pISSN - 1043-1802
DOI - 10.1021/acs.bioconjchem.1c00251
Subject(s) - chemistry , photosensitizer , singlet oxygen , photodynamic therapy , combinatorial chemistry , biocompatibility , conjugated system , drug delivery , conjugate , pegylation , azide , click chemistry , photochemistry , organic chemistry , polymer , mathematical analysis , mathematics , polyethylene glycol , oxygen
Stimuli-responsive recombinant elastin-like polypeptides (ELPs) are artificial protein polymers derived from the hydrophobic domain of tropoelastin that have attracted significant interest for drug delivery and tissue engineering applications. In the present study, we have conjugated a photosensitizer (PS) to a hydrophobic methionine-containing ELP scaffold, which upon reaction with singlet oxygen ( 1 O 2 ) is transformed into a hydrophilic sulfoxide derivative facilitating the disassembly of photosensitizer-delivery particles during the photodynamic therapy (PDT) process. A peripherally substituted carboxy-Zn(II)-phthalocyanine derivative (TT1) bearing a carboxyl group directly linked to the Pc-ring, and presenting an absorption maximum around 680 nm, was selected as PS which simultaneously acted as a photooxidation catalyst. A TT1 -ELP[M 1 V 3 - 40 ] conjugate was prepared from ELP[M 1 V 3 - 40 ] modified with an alkyne group at the N -terminal chain end, and from TT1-amide-C3-azide by copper(I)-catalyzed alkyne-azide cycloaddition (CuAAC) reaction. This innovative model photooxidation sensitive PS delivery technology offers promising attributes in terms of temperature-controlled particle formation and oxidation-triggered release, narrow molar mass distribution, reproducibility, scalability, non-immunogenicity, biocompatibility, and biodegradability for pharmaceutical applications in an effort to improve the clinical effectiveness of PDT treatments.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom